betulinic acid has been researched along with lactoferrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, S; Halder, A; Mukherjee, A; Roy, P; Saha, B; Shukla, D | 1 |
| Chatterji, U; Das, S; Ghosh, S; Halder, A; Helal Uddin, ABM; Jethwa, M; Mukherjee, A; Mukherjee, P; Roy, P | 1 |
2 other study(ies) available for betulinic acid and lactoferrin
| Article | Year |
|---|---|
Lactoferrin-modified Betulinic Acid-loaded PLGA nanoparticles are strong anti-leishmanials.
Topics: Amphotericin B; Animals; Anti-Inflammatory Agents; Antiparasitic Agents; Betulinic Acid; Cytokines; Lactoferrin; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Nanoparticles; Pentacyclic Triterpenes; Phosphorylcholine; Polylactic Acid-Polyglycolic Acid Copolymer; Triterpenes | 2018 |
Lactoferrin-tethered betulinic acid nanoparticles promote rapid delivery and cell death in triple negative breast and laryngeal cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Betulinic Acid; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Humans; Lactoferrin; Laryngeal Neoplasms; Nanoparticles; Particle Size; Pentacyclic Triterpenes; Triple Negative Breast Neoplasms | 2020 |